The United States stumbled badly with coronavirus testing. How will it distribute 300 million doses of vaccine?
IN Washington and on Wall Street, hopes for full social and economic recovery from the pandemic now hinge on the development of a coronavirus vaccine. With several large ongoing clinical trials and more than 165 vaccine candidates in development, chances are good that one will eventually prove to be effective.
Already a subscriber? Log in
The Star 6.6 DEAL: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
